Diagnostic accuracy of cytology and immunocytology in carcinomatous effusions

Background:  Immunocytology substantially improves the diagnostic accuracy of conventional cytology in the diagnosis of carcinomatous effusions. Due to the unequivocal characterization of the various cell populations, a sensitivity of 92% and specificity of 100% was achieved by immunocytology, examining samples of 1234 serous effusions.

[1]  N. Ordóñez.  Immunohistochemical diagnosis of epithelioid mesothelioma: an update. , 2009, Archives of pathology & laboratory medicine.

[2]  A. Gown,et al.  Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity , 2006, Modern Pathology.

[3]  N. Ordóñez.  Value of Immunohistochemistry in Distinguishing Peritoneal Mesothelioma From Serous Carcinoma of the Ovary and Peritoneum: A Review and Update , 2006, Advances in anatomic pathology.

[4]  W-Y Lee.  Limitations of detection of malignancy in pleural effusions using ELISA‐based TRAP assay: comparison with cytological examination , 2005, Cytopathology : official journal of the British Society for Clinical Cytology.

[5]  H. Sasano,et al.  Ber-EP4 and anti-calretinin antibodies: a useful combination for differential diagnosis of various histological types of ovarian cancer cells and mesothelial cells. , 2005, The Tohoku journal of experimental medicine.

[6]  C. Kandaraki,et al.  Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids , 2005, Diagnostic cytopathology.

[7]  M. Osterheld,et al.  Image cytometry: An aid for cytological diagnosis of pleural effusions , 2005, Diagnostic cytopathology.

[8]  T. Brezicka.  Expression of epithelial-cell adhesion molecule (Ep-CAM) in small cell lung cancer as defined by monoclonal antibodies 17-1A and BerEP4 , 2005, Acta oncologica.

[9]  C. Pan,et al.  The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases , 2004, Histopathology.

[10]  N. Ordóñez.  The diagnostic utility of immunohistochemistry in distinguishing between mesothelioma and renal cell carcinoma: a comparative study. , 2004, Human pathology.

[11]  B. Addis,et al.  Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies , 2002, Journal of clinical pathology.

[12]  A. Berner,et al.  Detection of malignant epithelial cells in effusions using flow cytometric immunophenotyping: an analysis of 92 cases. , 2002, American journal of clinical pathology.

[13]  Alfred Böcking,et al.  Diagnostic DNA-Flow- vs. -Image-Cytometry in Effusion Cytology , 2002, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

[14]  A. Berner,et al.  The Role of Desmin and N-Cadherin in Effusion Cytology: A Comparative Study Using Established Markers of Mesothelial and Epithelial Cells , 2001, The American journal of surgical pathology.

[15]  P. Fetsch,et al.  Immunocytochemistry in effusion cytology , 2001, Cancer.

[16]  P. Fetsch,et al.  Immunocytochemistry in effusion cytology: a contemporary review. , 2001 .

[17]  C. Comin,et al.  Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma. , 2001, Human pathology.

[18]  W. Grigioni,et al.  Immunohistochemical Panels For Differentiating Epithelial Malignant Mesothelioma From Lung Adenocarcinoma: A Study With Logistic Regression Analysis , 2001, The American journal of surgical pathology.

[19]  A. Nicholson,et al.  Value of the Mesothelium-Associated Antibodies Thrombomodulin, Cytokeratin 5/6, Calretinin, and CD44H in Distinguishing Epithelioid Pleural Mesothelioma from Adenocarcinoma Metastatic to the Pleura , 2000, Modern Pathology.

[20]  B. D. De Young,et al.  MOC‐31 aids in the differentiation between adenocarcinoma and reactive mesothelial cells , 1999, Cancer.

[21]  Alfred Böcking,et al.  Diagnostic accuracy of effusion cytology , 1999, Diagnostic cytopathology.

[22]  N. Ordóñez.  Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[23]  C. Bedrossian.  Diagnostic problems in serous effusions , 1998, Diagnostic cytopathology.

[24]  Leers,et al.  E‐cadherin and calretinin: a useful combination of immunochemical markers for differentiation between mesothelioma and metastatic adenocarcinoma , 1998, Histopathology.

[25]  C. Bedrossian.  Special stains, the old and the new: The impact of immunocytochemistry in effusion cytology , 1998, Diagnostic cytopathology.

[26]  G. Viale,et al.  Calretinin. A selective marker of normal and neoplastic mesothelial cells in serous effusions. , 1997, Acta cytologica.

[27]  G. Viale,et al.  Calretinin: a novel immunocytochemical marker for mesothelioma. , 1996, The American journal of surgical pathology.

[28]  L. Melínová,et al.  Diagnosis of pleural effusions. Experience with clinical studies, 1986 to 1990. , 1995, Chest.

[29]  M. Sidawy,et al.  Cytologic evaluation of serous effusions. Processing techniques and optimal number of smears for routine preparation. , 1993, American journal of clinical pathology.

[30]  S. Mills,et al.  Expression of "myelomonocytic" antigens in mesotheliomas and adenocarcinomas involving the serosal surfaces. , 1990, American journal of clinical pathology.

[31]  H. Stein,et al.  Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial. , 1990, Journal of clinical pathology.

[32]  B. Tribukait,et al.  Flow cytometric measurement of ploidy and proliferation in effusions of ovarian carcinoma and their possible prognostic significance. , 1989, Gynecologic oncology.

[33]  C. Herman,et al.  Cytology, immunopathology and flow cytometry in the diagnosis of pleural and peritoneal effusions. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[34]  P. Möller,et al.  Epithelium-specific surface glycoprotein of Mr 34,000 is a widely distributed human carcinoma marker. , 1987, British Journal of Cancer.

[35]  H. Ehya,et al.  Positive effusion cytology as the initial presentation of malignancy. , 1987, Acta cytologica.

[36]  P. Möller,et al.  Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues. , 1987, Cancer research.

[37]  P. Edwards.  Heterogeneous expression of cell-surface antigens in normal epithelia and their tumours, revealed by monoclonal antibodies. , 1985, British Journal of Cancer.

[38]  C. Kortsik,et al.  Immunocytochemical characterization of malignant mesothelioma and carcinoma metastatic to the pleura: IOB3—A new tumor marker , 2008, Lung.

[39]  N. Ordóñez.  The diagnostic utility of immunohistochemistry and electron microscopy in distinguishing between peritoneal mesotheliomas and serous carcinomas: a comparative study , 2006, Modern Pathology.

[40]  V. Najfeld,et al.  Chronic myelogenous leukemia: Prolonged survival with spontaneous decline in the frequency of Ph1‐positive cells and subsequent development of mixed Ph1‐positive and Ph1‐negative blast crisis , 1983, Cancer.

[41]  H. Stein,et al.  Ber-EP 4 : new monoclonal antibody which distinguishes epithelia from mesothelia , 2022 .